Emerging concept in DNA methylation: Role of transcription factors in shaping DNA methylation patterns

Journal of Cellular Physiology

Volumn 230, Issue 4, 2015, Pages 743-751

  Marchal, Claire ^a   Miotto, Benoit ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

CELL DIFFERENTIATION; DNA METHYLATION; ENVIRONMENTAL CHANGE; GENE EXPRESSION; GENE SILENCING; GENOME IMPRINTING; GERMLINE MUTATION; HUMAN; MACHINE; NEOPLASM; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; X CHROMOSOME INACTIVATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

MAMMALIA;

ANIMALS; CELL DIFFERENTIATION; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS; TRANSCRIPTION FACTORS;

EID: 84919754870     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24836     Document Type: Review

References (96)

1. Arab K, et al. 2014. Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A. Mol Cell 55:604-614.
2. Bartke T, et al. 2010. Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 143:470-484.
3. Blaschke K, et al. 2013. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 500:222-226.
4. Borgel J, et al. 2010. Targets and dynamics of promoter DNA methylation during early mouse development. Nat Genet 42:1093-1100.
5. Borrelli E, Nestler EJ, Allis CD, Sassone-Corsi P. 2008. Decoding the epigenetic language of neuronal plasticity. Neuron 60:961-974.
6. Bruniquel D, Schwartz RH. 2003. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 4:235-240.
7. Buck-Koehntop BA, Defossez P-A. 2013. On how mammalian transcription factors recognize methylated DNA. Epigenetics 8:131-137.
8. Buckley NJ, Johnson R, Sun Y-M, Stanton Is LW. 2009. REST a regulator of pluripotency? Nature 457:E5-E6.
9. Castro-Diaz N, et al. 2014. Evolutionally dynamic L1 regulation in embryonic stem cells. Genes Dev 28:1397-1409.
10. Chen J, et al. 2013. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat Genet 45:34-42.
11. Clouaire T, et al. 2012. Cfp1 integrates both CpG content and gene activity for accurate H3K4me3 deposition in embryonic stem cells. Genes Dev 26:1714-1728.
12. Cruvinel E, et al. 2014. Reactivation of maternal SNORD116 cluster via SETDB1 knockdown in Prader-Willi syndrome iPSCs. Hum Mol Genet 23:4674-4685.
13. Cunha S, et al. 2014. The RON receptor tyrosine kinase promotes metastasis by triggering MBD4-dependent DNA methylation reprogramming. Cell Rep 6:141-154.
14. De Smet C, Loriot A. 2013. DNA hypomethylation and activation of germline-specific genes in cancer. Adv Exp Med Biol 754:149-166.
15. De la Rica L, et al. 2013. PU. 1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation. Genome Biol 14:-R99.
16. Dennis K, Fan T, Geiman T, Yan Q, Muegge K. 2001. Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev 15:2940-2944.
17. Deplus R, et al. 2014. Regulation of DNA Methylation Patterns by CK2-Mediated Phosphorylation of Dnmt3a. Cell Rep 8:743-753.
18. Di Croce L, et al. 2002. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295:1079-1082.
19. Di Ruscio A, et al. 2013. DNMT1-interacting RNAs block gene-specific DNA methylation. Nature 503:371-376.
20. Dong E, Nelson M, Grayson DR, Costa E, Guidotti A. 2008. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc Natl Acad Sci U.S.A. 105:13614-13619.
21. Feldmann A, et al. 2013. Transcription factor occupancy can mediate active turnover of DNA methylation at regulatory regions. PLoS Genet 9:-e1003994.
22. Filion GJP, et al. 2006. A family of human zinc finger proteins that bind methylated DNA and repress transcription. Mol Cell Biol 26:169-181.
23. Fournier A, Sasai N, Nakao M, Defossez P-A. 2012. The role of methyl-binding proteins in chromatin organization and epigenome maintenance. Brief Funct Genomics 11:251-264.
24. Frietze S, O'Geen H, Blahnik KR, Jin VX, Farnham PJ. 2010. ZNF274 recruits the histone methyltransferase SETDB1 to the 3' ends of ZNF genes. PLoS ONE 5:e15082.
25. Gazin C, Wajapeyee N, Gobeil S, Virbasius C-M, Green MR. 2007. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 449:1073-1077.
26. Gibbons RJ, et al. 2000. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat Genet 24:368-371.
27. Gudbjartsson DF, et al. 2008. Many sequence variants affecting diversity of adult human height. Nat Genet 40:609-615.
28. Guibert S, Weber M. 2013. Functions of DNA methylation and hydroxymethylation in mammalian development. Curr Top Dev Biol 104:47-83.
29. Guo JU, Su Y, Zhong C, Ming G, Song H. 2011. Hydroxylation of 5-Methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145:423-434.
30. Hanna and Kelsey, Hanna CW, Kelsey G. 2014. The specification of imprints in mammals. Heredity (Edinb) 113:176-183.
31. Hendrich B, Hardeland U, Ng HH, Jiricny J, Bird A. 1999. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 401:301-304.
32. Hodges E, et al. 2011. Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. Mol Cell 44:17-28.
33. Hogart A, et al. 2012. Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites. Genome Res 22:1407-1418.
34. Hutchins AS, et al. 2002. Gene silencing quantitatively controls the function of a developmental trans-activator. Mol Cell 10:81-91.
35. Jørgensen HF, Chen Z-F, Merkenschlager M, Fisher AG. 2009. Is REST required for ESC pluripotency? Nature 457:E4-E5.
36. Joulie M, Miotto B, Defossez P-A. 2010. Mammalian methyl-binding proteins: What might they do. Bioessays 32:1025-1032.
37. Kaminskas E, et al. 2005. Approval summary: Azacitidine for treatment of myelodysplastic syndrome subtypes. Clin. Cancer Res 11:3604-3608.
38. Klose RJ, Bird AP. 2006. Genomic DNA methylation: The mark and its mediators. Trends Biochem Sci 31:89-97.
39. Kohli RM, Zhang Y. 2013. Enzymes, TDG and the dynamics of DNA demethylation. Nature 502:472-479.
40. Laget S, et al. 2014. MBD4 cooperates with DNMT1 to mediate methyl-DNA repression and protects mammalian cells from oxidative stress. Epigenetics 9:546-556.
41. Li X, et al. 2008. A maternal-zygotic effect gene, Zfp57, maintains both maternal and paternal imprints. Dev Cell 15:547-557.
42. Lienert F, et al. 2011. Identification of genetic elements that autonomously determine DNA methylation states. Nat Genet 43:1091-1097.
43. Lim DHK, Maher ER. 2010. Genomic imprinting syndromes and cancer. Adv Genet 70:145-175.
44. Lister R, et al. 2009. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462:315-322.
45. Liu Y, Toh H, Sasaki H, Zhang X, Cheng X. 2012. An atomic model of Zfp57 recognition of CpG methylation within a specific DNA sequence. Genes Dev 26:2374-2379.
46. Liu Y, Zhang X, Blumenthal RM, Cheng X. 2013. A common mode of recognition for methylated CpG. Trends Biochem Sci 38:177-183.
47. Lukic S, Nicolas J-C, Levine AJ. 2014. The diversity of zinc-finger genes on human chromosome 19 provides an evolutionary mechanism for defense against inherited endogenous retroviruses. Cell Death Differ 21:381-387.
48. Luo S-W, et al. 2009. Regulation of heterochromatin remodelling and myogenin expression during muscle differentiation by FAK interaction with MBD2. EMBO J 28:2568-2582.
49. Mackay DJG, et al. 2008. Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57. Nat Genet 40:949-951.
50. Maeda I, et al. 2013. Max is a repressor of germ cell-related gene expression in mouse embryonic stem cells. Nat Commun 4:1754.
51. Maeder ML, et al. 2013. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat. Biotechnol 31:1137-1142.
52. Makar KW, et al. 2003. Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells. Nat Immunol 4:1183-1190.
53. Martinowich K, et al. 2003. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302:890-893.
54. Messerschmidt DM, Knowles BB, Solter D. 2014. DNA methylation dynamics during epigenetic reprogramming in the germline and preimplantation embryos. Genes Dev 28:812-828.
55. Molaro A, et al. 2014. Two waves of de novo methylation during mouse germ cell development. Genes Dev 28:1544-1549.
56. Murayama A, et al. 2006. A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory. EMBO J 25:1081-1092.
57. Murgatroyd C, et al. 2009. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci 12:1559-1566.
58. Nitta H, et al. 2013. Three novel ZBTB24 mutations identified in Japanese and Cape Verdean type 2 ICF syndrome patients. J Hum Genet 58:455-460.
59. Oda M, et al. 2013. DNA methylation restricts lineage-specific functions of transcription factor Gata4 during embryonic stem cell differentiation. PLoS Genet 9:-e1003574.
60. Oikawa Y, et al. 2011. The methyl-CpG-binding protein CIBZ suppresses myogenic differentiation by directly inhibiting myogenin expression. Cell Res 21:1578-1590.
61. Okano M, Bell DW, Haber DA, Li E. 1999. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99:247-257.
62. Pacaud R, et al. 2014. DNMT3L interacts with transcription factors to target DNMT3L/DNMT3B to specific DNA sequences: Role of the DNMT3L/DNMT3B/p65-NFκB complex in the (de-) methylation of TRAF1. Biochimie 104:36-49.
63. Palacios D, Summerbell D, Rigby PWJ, Boyes J. 2010. Interplay between DNA methylation and transcription factor availability: Implications for developmental activation of the mouse Myogenin gene. Mol Cell Biol 30:3805-3815.
64. Palakurthy RK, et al. 2009. Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression. Mol Cell 36:219-230.
65. Petrie K, et al. 2008. Retinoblastoma protein and the leukemia-associated PLZF transcription factor interact to repress target gene promoters. Oncogene 27:5260-5266.
66. Project Consortium. ENCODE. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:57-74.
67. Puszyk W, et al. 2013. The epigenetic regulator PLZF represses L1 retrotransposition in germ and progenitor cells. EMBO J 32:1941-1952.
68. Quenneville S, et al. 2011. In embryonic stem cells, ZFP57/KAP1 recognize a methylated hexanucleotide to affect chromatin and DNA methylation of imprinting control regions. Mol Cell 44:361-372.
69. Quenneville S, et al. 2012. The KRAB-ZFP/KAP1 system contributes to the early embryonic establishment of site-specific DNA methylation patterns maintained during development. Cell Rep 2:766-773.
70. Rowe HM, et al. 2010. KAP1 controls endogenous retroviruses in embryonic stem cells. Nature 463:237-240.
71. Rowe HM, et al. 2013. De novo DNA methylation of endogenous retroviruses is shaped by KRAB-ZFPs/KAP1 and ESET. Development 140:519-529.
72. Serra RW, Fang M, Park SM, Hutchinson L, Green MR. 2014. A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype. Elife 3:-e02313.
73. Sharif J, et al. 2007. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450:908-912.
74. Singh SK, Kagalwala MN, Parker-Thornburg J, Adams H, Majumder S. 2008. REST maintains self-renewal and pluripotency of embryonic stem cells. Nature 453:223-227.
75. Smith ZD, Meissner A. 2013. DNA methylation: Roles in mammalian development. Nat Rev Genet 14:204-220.
76. Spruijt CG, et al. 2013. Dynamic readers for 5-(hydroxy) methylcytosine and its oxidized derivatives. Cell 152:1146-1159.
77. Stadler MB, et al. 2011. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 480:490-495.
78. Subramaniam D, Thombre R, Dhar A, Anant S. 2014. DNA methyltransferases: A novel target for prevention and therapy. Front Oncol 4:80.
79. Takikawa S, et al. 2013. Human and mouse ZFP57 proteins are functionally interchangeable in maintaining genomic imprinting at multiple imprinted regions in mouse ES cells. Epigenetics 8:1268-1279.
80. Tan X, et al. 2013. Zfp819, a novel KRAB-zinc finger protein, interacts with KAP1 and functions in genomic integrity maintenance of mouse embryonic stem cells. Stem Cell Res 11:1045-1059.
81. Teif VB, et al. 2014. Nucleosome repositioning links DNA (de) methylation and differential CTCF binding during stem cell development. Genome Res 24:1285-1295.
82. Thillainadesan G, et al. 2012. TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex. Mol Cell 46:636-649.
83. Thomson JP, et al. 2010. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 464:1082-1086.
84. Turelli P, et al. 2014. Interplay of TRIM28 and DNA methylation in controlling human endogenous retroelements. Genome Res 24:1260-1270.
85. Velasco G, et al. 2010. Dnmt3b recruitment through E2F6 transcriptional repressor mediates germ-line gene silencing in murine somatic tissues. Proc Natl Acad Sci U.S.A. 107:9281-9286.
86. Viré E, et al. 2006. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439:871-874.
87. Wajapeyee N, Malonia SK, Palakurthy RK, Green MR. 2013. Oncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressors. Genes Dev 27:2221-2226.
88. Weaver ICG, et al. 2007. The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes. J Neurosci 27:1756-1768.
89. Weng Y-L, An R, Shin J, Song H, Ming G. 2013. DNA modifications and neurological disorders. Neurotherapeutics 10:556-567.
90. Wolf D, Goff SP. 2007. TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 131:46-57.
91. Wolf D, Goff SP. 2009. Embryonic stem cells use ZFP809 to silence retroviral DNAs. Nature 458:1201-1204.
92. Wu L, Zheng Q. 2014. Active demethylation of the IL-2 Promoter in CD4+ T cells is mediated by an inducible DNA glycosylase, Myh. Mol Immunol 58:38-49.
93. Zane L, Sharma V, Misteli T. 2014. Common features of chromatin in aging and cancer: Cause or coincidence. Trends Cell Biol. DOI: 10.1016/j.tcb.2014.07.001.
94. Zhang B, et al. 2012. The p16-specific reactivation and inhibition of cell migration through demethylation of CpG islands by engineered transcription factors. Hum Gene Ther 23:1071-1081.
95. Zhou JC, Blackledge NP, Farcas AM, Klose RJ. 2012. Recognition of CpG island chromatin by KDM2A requires direct and specific interaction with linker DNA. Mol Cell Biol 32:479-489.
96. Ziller MJ, et al. 2013. Charting a dynamic DNA methylation landscape of the human genome. Nature 500:477-481.